UK Biotech Biz To Cancel AIM Listing Amid Administration
Troubled U.K. biotechnology company ReNeuron Group PLC said Friday that it will delist its shares from the London Stock Exchange on Sept. 2 on the recommendation of its administrators, after remaining suspended...To view the full article, register now.
Already a subscriber? Click here to view full article